Komori
Almado (4932) · TargetAdvanced

Expanding existing sales channels and establishing new growth drivers

First written in FY2021. 21 of 22 entries say "Advanced", first in FY2022-Q2. Latest entry: 2026-11-13.

22entries
6years
7from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q2 – 2026-11-132021: 220212022: 420222023: 420232024: 220242025: 220252026: 82026
Same theme, other companies
Sales Growth Through New Product Launches and Expanded Sales ChannelsA theme 12 companies write about · 0 as a headwind · 12 as a tailwind

The whole theme swung hardest in 2025: 2 of 8 companies on the "Worse" side.

6 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In direct-to-consumer (EC), the number of new customers acquired and recurring members remained strong following the airing of a television commercial for men's skincare products containing eggshell membrane. Revenue also increased year on year as EC marketplace sales expanded steadily. In external sales through general retail, revenue increased substantially year on year as the number of drugstores and variety stores carrying the products expanded. In external OEM sales, revenue declined year on year as the number of orders from OEM customers decreased. TV shopping revenue declined year on year because major programs fell short of budget.」

    Direct-to-consumer EC and general retail sales expanded, while OEM sales and TV shopping sales declined. Channel expansion progressed at different rates by channel, and revenue was ¥10,118.869 million, or 119.4% of the prior-year period.
  2. FY2026-H1AdvancedAnnual report

    「Following the airing of a television commercial for men's skincare products containing eggshell membrane, direct-to-consumer (EC) recorded all-time highs in new customer acquisition and recurring members, and revenue increased year on year. In external sales through general retail, revenue increased year on year as the number of drugstores and variety stores carrying the products expanded. In external OEM sales, revenue declined year on year because delivery of some products was postponed. TV shopping revenue declined year on year because some major and mid-sized programs fell short of budget.」

    Direct-to-consumer EC recorded all-time highs in new customer acquisition and recurring members, while the number of drugstores and variety stores carrying the products expanded in general retail. OEM sales declined because delivery was postponed, and TV shopping sales declined because programs fell short of budget.
  3. FY2025AdvancedAnnual report

    「We strengthened advertising operations and took other measures aimed at further increasing awareness of eggshell membrane products. Direct-to-consumer (EC) customer acquisition reached a record high, and revenue increased year on year as the number of recurring members grew. In external sales through general retail, revenue increased year on year as the expansion in the number of stores carrying Cherlular products was strong. In external OEM sales, revenue declined year on year because shipment volumes to OEM customers were below the prior fiscal year. TV shopping revenue also declined year on year after some major programs fell short of budget amid consumers' increased focus on saving.」

    Direct-to-consumer EC and general retail sales expanded, while OEM sales and TV shopping sales declined. Expansion of existing sales channels is progressing at different rates across channels.
  4. FY2025-H1AdvancedAnnual report

    「Against this backdrop, under our 3 management visions (*1), we strengthened advertising operations and took other measures aimed at further increasing awareness of eggshell membrane products. Direct-to-consumer (EC) customer acquisition reached a record high, and the number of recurring members increased substantially from the prior fiscal year, resulting in higher revenue year on year. In external sales through general retail, revenue increased year on year as the number of stores carrying Cherlular products expanded substantially. In external OEM sales, revenue declined year on year because shipment volumes to OEM customers were lower than in the prior fiscal year, as expected. TV shopping revenue also declined year on year after some major programs fell short of budget amid consumers' increased focus on saving.」

    Direct-to-consumer EC customer acquisition reached a record high, while the number of stores carrying Cherlular products expanded in general retail. OEM sales and TV shopping sales declined, indicating uneven progress across sales channels.
  5. FY2024-Q3AdvancedAnnual report

    「Against this backdrop, under our 3 management visions (*1), we aired a new television commercial aimed at further increasing awareness of eggshell membrane serum, but the number of new direct-to-consumer (EC) customers acquired declined year on year. However, the expansion of the recurring customer base and higher recurring purchase retention rate in the prior year paid off, and revenue increased year on year. Shipments in the external sales channel (OEM sales) also remained strong year on year. TV shopping sales also exceeded the prior-year period, supported by strong year-end performance.」

    Although the number of new direct-to-consumer customers acquired declined, the recurring customer base and retention rate, OEM shipments and year-end TV shopping contributed to performance. Revenue for the cumulative 3rd quarter was ¥5,772.673 million, or 119.2% of the prior-year period.
  6. FY2024-Q2AdvancedAnnual report

    「Against this backdrop, under our 3 management visions (*1), we aired a new television commercial aimed at further increasing awareness of eggshell membrane serum, but the number of new direct-to-consumer (EC) customers acquired declined year on year. However, the expansion of the recurring customer base and higher recurring purchase retention rate in the prior year paid off, and revenue increased year on year. Shipments in the external sales channel (OEM sales) also remained strong year on year.」

    Direct-to-consumer (EC) sales were 126.5% of the prior-year period, while OEM sales were 129.5%, indicating progress in expanding both direct-to-consumer and OEM channels. TV shopping sales, however, were below the prior-year period.
  7. FY2024-Q1AdvancedAnnual report

    「Against this backdrop, under our 3 management visions (*1), we aired a new television commercial aimed at further increasing awareness of eggshell membrane serum, but the number of new direct-to-consumer (EC) customers acquired declined year on year. However, the expansion of the recurring customer base and higher recurring purchase retention rate in the prior year paid off, and revenue increased year on year. Shipments in the external sales channel (OEM sales) also remained strong year on year.」

    Although the number of new customers acquired declined year on year, revenue increased 35.5% year on year to ¥2,065.630 million, supported by growth in the recurring customer base and retention rate and strong OEM shipments.
  8. FY2023AdvancedAnnual report

    「We aim to expand our share through existing sales channels, develop new channels as a new pillar of growth, and strengthen the development of products that will serve as a new pillar alongside our existing brands, thereby driving the expansion of the eggshell membrane market.」

    Revenue for the fiscal year increased 21.7% year on year, driven by growth in direct-to-consumer (EC) and general retail sales. OEM sales, however, declined to 87.7% of the prior-year period.
  9. FY2023-Q3AdvancedAnnual report

    「Revenue increased as the number of new direct-sales customers expanded following the airing of television commercials aimed at raising awareness of the eggshell membrane serum. However, profit declined because advertising expenses were incurred temporarily and in substantial amounts.」

    Television advertising expanded the number of new direct-to-consumer customers acquired and revenue. Direct-to-consumer (EC) revenue was ¥2,546.861 million, or 165.3% of the prior-year period, while OEM sales declined to 72.7% of the prior-year period.
  10. FY2023-Q2AdvancedAnnual report

    「Against this backdrop, under the 3 management visions (*1), revenue increased as new direct-sales customer acquisition expanded following the airing of television commercials aimed at raising awareness of the eggshell membrane serum. However, profit declined because advertising expenses were incurred temporarily and in substantial amounts.」

    New-customer acquisition in direct sales expanded due to television commercials, and direct-sales (EC) revenue was ¥1,646.063 million, or 161.9% of the year-earlier level. Meanwhile, OEM sales were 94.6% of the year-earlier level.
  11. FY2023-Q1AdvancedAnnual report

    「Against this backdrop, under the 3 management visions (*1), revenue increased as the number of new direct-sales customers expanded following the airing of television commercials aimed at raising awareness of the eggshell membrane serum. However, profit declined because advertising expenses were incurred temporarily and in substantial amounts. Direct sales (EC) 492,961 40.4 782,097 51.3 289,135 158.7」

    The number of new direct-sales customers increased following the airing of television commercials, and direct-sales (EC) revenue was ¥782.097 million, or 158.7% of the year-earlier level.
  12. FY2022AdvancedAnnual report

    「External sales revenue, including OEM sales, increased substantially as trading volumes recovered following the resolution of excess inventory held by OEM customers, which had been a factor in the decline in revenue in the previous fiscal year.」

    OEM sales were ¥1,742.440 million, equivalent to 155.9% of the year-earlier level, and the company disclosed progress in expanding sales channels through the resolution of excess inventory.
  13. FY2022-Q3AdvancedAnnual report

    「Against this backdrop, under the 3 management visions (*1), direct sales of new customers performed well, supported by increased advertising aimed at raising awareness of eggshell membrane products, while external sales also progressed steadily, with shipments to OEM customers increasing year on year.」

    In addition to strong new-customer acquisition in direct sales, OEM sales increased 69.2% year on year to ¥1,305.490 million, indicating progress in expanding existing sales channels.
  14. FY2022-Q2AdvancedAnnual report

    「Against this backdrop, direct sales of new customers performed well, supported by increased advertising aimed at raising awareness of eggshell membrane products, while external sales also progressed steadily, with shipments to OEM customers increasing year on year.」

    The company reported progress in expanding sales channels, including strong new-customer acquisition in direct sales driven by increased advertising and higher shipments to OEM customers.
  15. FY2021First statedAnnual report

    「We will seek to drive expansion of the eggshell membrane market by increasing our share in existing sales channels, developing new sales channels as new growth drivers, and strengthening the development of products that will become new core offerings following our existing brands.」

    The company aims to expand the eggshell membrane market by combining existing sales channels, new sales channels and new products.
Moved together

"Expanding direct-to-consumer channel revenue and profit" moved the same way as this thread, in the same document, in 21 of its 22 moves.

211110998★123456
  1. ★This thread
  2. 1Expanding direct-to-consumer channel revenue and profit21×
  3. 2Expanding recurring-purchase customers and strengthening customer relationships11×
  4. 3Increasing awareness of Almado, eggshell membrane and type III collagen10×
  5. 4Expansion of Revenue, Gross Profit and Operating Profit9×
  6. 5Restricted stock compensation for employees and directors9×
  7. 6Risk of direct-sales expansion measures failing to deliver results8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Almado's next results are scheduled for 2026-11-13. Read the earnings preview It last moved in the Earnings presentation of 2026-11-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding existing sales channels and establishing new growth drivers | ALMADO,INC. (4932) | Komori